期刊文献+

医疗器械临床应用评价方案与实践 被引量:4

The Assessment Scheme and Practice of Clinical Application of Medical Equipment
暂未订购
导出
摘要 以不同品牌的多参数监护仪为例,依据医疗器械的生命周期,拟定医疗器械应用评价的多维度因素(技术要求、质量控制、临床使用、维修和不良事件)。通过德尔菲法评估每种因素的重要性,设计了医疗器械临床应用评价方案,对多参数监护仪进行综合评价,旨在评估医疗器械的安全性、有效性,促进医疗器械功能完善,提高医疗器械的采购质量。 Taking different brands of multi-parameter monitors as an example,according to the life cycle of medical equipment,multi-dimensional factors(technical requirements,quality control,clinical use,maintenance and adverse events)of medical equipment application evaluation are formulated.The importance of each factor is evaluated by Delphi method.The clinical application evaluation scheme of medical equipment is designed.The multi-parameter monitor is comprehensively evaluated,aiming to evaluate the safety and effectiveness of medical equipment,promote the improvement of medical equipment functions,and improve the procurement quality of medical equipment.
作者 杨利 黄靖 张本兴 魏安海 张和华 YANG Li;HUANG Jing;ZHANG Benxing;WEI Anhai;ZHANG Hehua
出处 《中国医院建筑与装备》 2022年第12期15-18,共4页 Chinese Hospital Architecture & Equipment
基金 重庆市社会事业与民生保障科技创新专项(cstc2017shmsA130074) 陆军军医大学临床医学科研人才资助项目(2019XLC3055)。
关键词 医疗器械评价 多参数监护仪 质量控制 德尔菲法 Evaluation of medical equipment Multi-parameter monitors Quality control The Delphi method
  • 相关文献

参考文献11

二级参考文献118

  • 1田丽姗,姚艳冬,周维,周延召,范明,高月.高原驻防驻训官兵睡眠障碍防治研究进展[J].军事医学,2020,44(7):546-551. 被引量:27
  • 2周小龙.医疗设备采购与验收风险防控管理措施研究[J].大众标准化,2020(24):229-230. 被引量:3
  • 3张文明.国外关于密闭环境中二氧化碳对机体的影响及其卫生标准研究概况[J].解放军预防医学杂志,1994,12(1):83-86. 被引量:10
  • 4Babapuile MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomized clinical trials of durg-eluting stents. Lancet, 2004, 364: 583-591.
  • 5Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet, 2007, 369: 667-678.
  • 6Kimura T, Morimoto T, Nakagawa Y, el al. Anliplatelet therapy and stent thrombosis after sirolimuseluting stent implantation. Circulation, 2009, 119: 987-995.
  • 7Nishio S, Kosuga K, lgaki K, et al. Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation, 2012, 125: 2343-2353.
  • 8Finesehi M, Cori T, Pierli C, et at. Outcome of percutaneous hybrid earonary revascularization: bare metal stents jeopardize the Irenefit of sirolimus-elufing stents in the real world. CanJ Cardiol, 2005, 21: 1281-1285.
  • 9Fineschi M, Gori T, Pierli C, et al. On behalf of the Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 2007, 115:2344-2351.
  • 10D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med, 1998, 17: 2265-2281.

共引文献153

同被引文献93

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部